
Auris Health
Total Raised
$733.29MInvestors Count
12Deal Terms
5Investments
1Funding, Valuation & Revenue
8 Fundings
Auris Health has raised $733.29M over 8 rounds.
Auris Health's latest funding round was a Acquired for on February 13, 2019.
Auris Health's valuation in August 2017 was $1,280M.
Auris Health's latest post-money valuation is from February 2019.
Sign up for a free demo to see Auris Health's valuations in February 2019 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/13/2019 | Acquired | 7 | ||||
11/28/2018 | Series E | |||||
8/4/2017 | Series D | $1,280M | ||||
8/9/2016 | Series C | |||||
9/23/2015 | Series B |
Date | 2/13/2019 | 11/28/2018 | 8/4/2017 | 8/9/2016 | 9/23/2015 |
|---|---|---|---|---|---|
Round | Acquired | Series E | Series D | Series C | Series B |
Amount | |||||
Investors | |||||
Valuation | $1,280M | ||||
Revenue | |||||
Sources | 7 |
Auris Health Deal Terms
5 Deal Terms
Auris Health's deal structure is available for 5 funding rounds, including their Acquired from February 13, 2019.
Round | Acquired | Series D | Series C | Series B | Series A |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Series D | |||||||||||||||
Series C | |||||||||||||||
Series B | |||||||||||||||
Series A |
Auris Health Investors
12 Investors
Auris Health has 12 investors. Johnson & Johnson invested in Auris Health's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
2/13/2019 | 2/13/2019 | 1 Acquired | Corporation | New Jersey | ||
3/31/2014 | 11/28/2018 | Lux Capital | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | Venture Capital | New York | |
3/31/2014 | 11/28/2018 | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | Venture Capital | Texas | ||
Asset/Investment Management | New York | |||||
Venture Capital | California |
First funding | 2/13/2019 | 3/31/2014 | 3/31/2014 | ||
|---|---|---|---|---|---|
Last Funding | 2/13/2019 | 11/28/2018 | 11/28/2018 | ||
Investor | Lux Capital | ||||
Rounds | 1 Acquired | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Asset/Investment Management | Venture Capital |
Location | New Jersey | New York | Texas | New York | California |
Auris Health Acquisitions
1 Acquisition
Auris Health acquired 1 company. Their latest acquisition was Hansen Medical on April 20, 2016.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
4/20/2016 | Other Venture Capital | $57.8M | Acquired | 5 |
Date | 4/20/2016 |
|---|---|
Investment Stage | Other Venture Capital |
Companies | |
Valuation | |
Total Funding | $57.8M |
Note | Acquired |
Sources | 5 |
Auris Health Investments
1 Investments
Auris Health has made 1 investments. Their latest investment was in Qool Therapeutics as part of their Series B on November 08, 2017.
Auris Health Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/8/2017 | Series B | Qool Therapeutics | $13.96M | Yes | 1 |
Date | 11/8/2017 |
|---|---|
Round | Series B |
Company | Qool Therapeutics |
Amount | $13.96M |
New? | Yes |
Co-Investors | |
Sources | 1 |
Compare Auris Health to Competitors

Asensus Surgical provides robotic-assisted surgical technology and digital laparoscopic systems within the healthcare sector. The company offers products aimed at improving surgeon control and addressing variability during surgical procedures, utilizing augmented intelligence and real-time insights. Asensus Surgical serves the healthcare industry, targeting surgeons and hospital administrators. Asensus Surgical was formerly known as TransEnterix. It was founded in 2006 and is based in Durham, North Carolina.

CMR Surgical operates as a global medical devices company that specializes in surgical robotics within the healthcare industry. The company offers Versius, a surgical robot designed for robotic minimal access surgery. CMR Surgical collaborates with healthcare professionals to improve the accessibility and affordability of robotic-assisted surgical procedures. CMR Surgical was formerly known as Cambridge Medical Robotics. It was founded in 2014 and is based in Cambridge, United Kingdom.

Quantum Surgical is a medical device company that develops robotic-assisted technologies for cancer treatment within the interventional oncology sector. The company's main offering, the Epione® platform, is designed to plan, target, deliver, and confirm tumor ablation using robotics and image fusion technology. Quantum Surgical's solutions cater to the healthcare sector, providing tools for clinicians to perform procedures on inoperable or hard-to-reach tumors. It was founded in 2017 and is based in Montpellier, France.

Activ Surgical focuses on intraoperative surgical intelligence within the medical technology sector. The company offers products that provide visual insights and information to surgeons, allowing them to see physiological structures and functions during surgery. These products integrate with existing surgical systems and are compatible with minimally invasive procedures. Activ Surgical was formerly known as OMNIBOROS, INC. It was founded in 2017 and is based in Boston, Massachusetts.

Theator operates within the healthcare technology sector and focuses on its surgical intelligence platform. The platform captures, manages, and analyzes surgical video data using artificial intelligence (AI) to improve surgical quality and efficiency. It serves hospitals and healthcare providers and integrates surgical video with patient outcomes and operational analytics. It was founded in 2018 and is based in Palo Alto, California.
Asia Pacific Medical Technology Association (APACMed) operates as a trade association and represents the medical devices and in-vitro diagnostics industry in Asia Pacific. APACMed engages in various activities, such as government affairs, market access, legal and compliance, regulatory affairs, and supporting digital health initiatives. It was founded in 2014 and is based in Singapore.
Loading...

